ClearNote Health’s enhanced Avantect Pancreatic Cancer Test delivers industry-leading early detection performance
Proprietary multianalyte and multiomic assay with optimized machine learning capabilities achieve significantly higher 82% sensitivity and 97% specificity in high-risk populations
























